Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
H M KlugerL B Jilaveanu

Abstract

Programmed death ligand-1 (PD-L1) tumor expression represents a mechanism of immune escape for melanoma cells. Drugs blocking PD-L1 or its receptor have shown unprecedented activity in melanoma, and our purpose was to characterize tumor PD-L1 expression and associated T-cell infiltration in metastatic melanomas. We used a tissue microarray (TMA) consisting of two cores from 95 metastatic melanomas characterized for clinical stage, outcome, and anatomic site of disease. We assessed PD-L1 expression and tumor-infiltrating lymphocyte (TIL) content (total T cells and CD4/CD8 subsets) by quantitative immunofluorescence. High PD-L1 expression was associated with improved survival (P = 0.02) and higher T-cell content (P = 0.0005). Higher T-cell content (total and CD8 cells) was independently associated with improved overall survival; PD-L1 expression was not independently prognostic. High TIL content in extracerebral metastases was associated with increased time to developing brain metastases (P = 0.03). Cerebral and dermal metastases had slightly lower PD-L1 expression than other sites, not statistically significant. Cerebral metastases had less T cells (P = 0.01). T-cell-infiltrated melanomas, particularly those with high CD8 T-cell...Continue Reading

References

Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·P'ng Loke, James P Allison
Jun 17, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mary M McCarthyHarriet M Kluger
Nov 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M M McCarthyH M Kluger
Sep 10, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lucia B JilaveanuHarriet M Kluger
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 14, 2011·Current Problems in Cancer·Jaclyn C FlaniganHarriet M Kluger
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Mar 9, 2013·Nature Reviews. Immunology·Lieping Chen, Dallas B Flies
May 23, 2013·Cancer·Ronald HamiltonStergios Moschos
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Aug 30, 2013·Science Translational Medicine·Stefani SprangerThomas F Gajewski
Nov 13, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Vamsidhar VelchetiDavid L Rimm
Feb 11, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew GibsonDean J Naisbitt
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Mar 22, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kurt A SchalperDavid L Rimm
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
May 24, 2014·International Archives of Allergy and Immunology·W H FridmanCatherine Sautès-Fridman
Jul 6, 2014·Frontiers in Immunology·Marie T Kim, John T Harty
Jul 18, 2014·Journal for Immunotherapy of Cancer·Michael K WongMichael A Morse
Oct 16, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lucia B JilaveanuHarriet M Kluger
Oct 21, 2014·The Lancet Oncology·Sanjeet Bagcchi
Nov 5, 2014·Cancer Discovery

❮ Previous
Next ❯

Citations

Feb 7, 2016·BMC Medicine·Jason M RedmanMichael B Atkins
Jan 19, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhong-Yi DongYi-Long Wu
Jan 23, 2016·Annales de dermatologie et de vénéréologie·N Meyer
Feb 2, 2016·The Journal of Investigative Dermatology·Nicolas JacquelotLaurence Zitvogel
Nov 28, 2015·Thoracic Surgery Clinics·Michael A Morse
Sep 14, 2016·Oncoimmunology·S Harrison FarberPeter E Fecci
May 20, 2016·Annual Review of Pathology·Scott B Lovitch, Scott J Rodig
Sep 7, 2016·International Journal of Molecular Sciences·David A KircherSheri L Holmen
Jan 24, 2017·Annales de pathologie·Julien AdamCaroline Robert
Apr 5, 2017·Current Treatment Options in Neurology·Anna S Berghoff, Matthias Preusser
Apr 21, 2018·Journal of Pathology and Translational Medicine·Hermin Aminah UsmanReti Hindritiani
Aug 18, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Sabrina RossiEgesta Lopci
Nov 9, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harriet M KlugerLucia B Jilaveanu
Oct 26, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diwakar DavarHassane M Zarour
Jan 9, 2018·Nature Medicine·Carsten KriegBurkhard Becher
Nov 15, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·Edwin R ParraJaime Rodriguez-Canales
Oct 14, 2017·Journal of Gynecologic Oncology·Jun ZhuXiaohua Wu
May 18, 2019·American Society of Clinical Oncology Educational Book·Priscilla BrastianosHelena A Yu
May 23, 2019·Journal of Cancer Research and Clinical Oncology·Liyuan ZhouBinquan Wang
Aug 14, 2019·Current Opinion in Oncology·Valérie DutoitPierre-Yves Dietrich
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Kristen R SpencerJanice M Mehnert
Sep 20, 2019·Journal for Immunotherapy of Cancer·Swati GuptaDavid L Rimm
Jan 19, 2019·Nature Reviews. Disease Primers·Achal Singh AchrolSteven D Chang
May 31, 2019·Archives of Pharmacal Research·Su-Myeong Park, Je-In Youn
Apr 5, 2019·Oncology Letters·Monica NeaguSabina Zurac
May 26, 2017·Cancer·Dana WestphalHeike Niessner
Jun 22, 2017·International Journal of Urology : Official Journal of the Japanese Urological Association·Wataru ObaraRyo Takata
Nov 25, 2017·Cancer Biomarkers : Section a of Disease Markers·Dan TanQing-Hua Yi
Aug 30, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Miseon LeeHee Jin Lee
Apr 7, 2019·Cancer Immunology, Immunotherapy : CII·Lucie DuvergerMaxime Battistella
May 28, 2019·NPJ Precision Oncology·Su Bin LimChwee Teck Lim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
D MassiM Mandalà
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Min-hua ShiYong-jing Chen
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Sukhmani K PaddaHeather A Wakelee
© 2021 Meta ULC. All rights reserved